Translation is defined as the process of turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public. It may be, but is not limited to:

  • the process of making discoveries in the research laboratory or in preclinical studies that will have an impact on human health and may lead to the development of studies in humans
  • the process of applying discoveries generated during research in the laboratory, and in preclinical studies, to the development of trials and studies in humans and/or
  • research aimed at but not limited to defining and/or adopting of new health policies/guidelines or health systems change.

The purpose of this award is to raise awareness and the profile of its awardee and the significance of their work that has contributed an important step towards the eventual goal of impacting human health.

Eligibility criteria and Conditions

  • The nominee can be any researcher or part of a team of researchers, irrespective of discipline or career stage but their work needs to have relevance to improving cardiovascular health outcomes, whether in the short, medium or long term. The nominee needs to show the impact, effort and innovation, and the change/contribution that their research has played in the translation pathway. For example, the nominee for the award may be undertaking basic, clinical, population or health services research; they may be from a non-medical discipline, e.g. a bioinformatics or engineering background, but will need to have undertaken significant steps that result in the research findings moving to the next stage in implementation.
  • The nominee does not have to be an ACvA member.


  • The awardee must demonstrate their ongoing commitment through championship of the sector and stakeholder engagement.

How to nominate

  • The nomination can be made by anyone, including themselves.
  • The nomination should include evidence of the translational impact of and pathway for the work. This could include validation by:
    • Clinicians
    • Hospital or LHD Executives
    • Clinical trialists
    • Experts in pre-clinical work
    • Funding bodies (eg Heart Foundation, Stroke Foundation)
    • Industry
    • Government
    • Publication(s).
  • At least one referee must be from an external organisation separate from the nominee.
  • Completing the attached template is all that is required for the nomination.

Nomination assessment

  • The key criteria will be demonstrating that the research undertaken by the nominee will be an important step towards the eventual goal of impacting human health, and that the pathway to this impact is clear and validated as per the nomination form.
  • The translation nominations will be provided to a review panel who select the award based on the above criteria.

Closing date

Nominations close 31 August 2021.